Patents by Inventor Kyla Elizabeth Driscoll

Kyla Elizabeth Driscoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD200 RECEPTOR ANTAGONIST BINDING MOLECULES
    Publication number: 20220396619
    Abstract: The present invention relates to antagonist polypeptide molecules that bind to human CD200 receptor, and are useful for treating solid tumors, alone and in combination with chemotherapy, ionizing radiation, an antitumor agent and/or an immuno-oncology agent.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 15, 2022
    Inventors: Katherine Marie BELL-MCGUINN, Stephen John DEMAREST, Kyla Elizabeth DRISCOLL, Rikke Baek HOLMGAARD, Anna Marie RUSSELL, Jaafar Nassar SLEIMAN HAIDAR, Derrick Ryan WITCHER
  • USE OF 2-{4-[(4-{[1-CYCLOPROPYL-3-TETRAHYDRO-2H-PYRAN-4-yl)-1H-PYRAZOL-4yl]OXY} PYRIDINE-2-yl)AMINO]PYRIDIN-2-yl}PROPAN-2-OL IN THE TREATMENT OF CANCER
    Publication number: 20190216786
    Abstract: The present invention relates to novel methods of using 2-{4-[(4-{[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy}pyridin-2-yl)amino]pyridin-2-yl}propan-2-ol or a pharmaceutically acceptable salt thereof to treat physiological conditions such as cancer.
    Type: Application
    Filed: September 22, 2017
    Publication date: July 18, 2019
    Inventors: Karim Adnane BENHADJI, Kyla Elizabeth DRISCOLL, Michael Mauritius Fabio LAHN, Jason Scott SAWYER, Anja Jamandre STAUBER
  • TGFbeta Receptor II Antibodies
    Publication number: 20180105597
    Abstract: The present invention relates to antibodies that bind TGF? receptor II (TGF?RII), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 19, 2018
    Inventors: Douglas Bryan Burtrum, Kyla Elizabeth Driscoll